LeállítvaKorai 1. fázis
Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice
A legfontosabb adatok
- Ki végzi
- Joshua A. Lile, Ph.D.
- Hol
- Lexington (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Fázis
- Korai 1. fázis
- Résztvevők
- 2 fő vett részt
- Kezdés
- 2023. márc. 1.
- Befejezés
- 2025. márc. 28.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Drug Cue
- Money
- Withdrawal
- Remifentanil
- A regiszteradat frissítve
- 2026. március 30.
- Miért állt le
- Funding ended
Ki vehet részt
- Életkor
- 18 év – 50 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Individuals must meet criteria for moderate/severe opioid use disorder, report past month opioid misuse, and be physically dependent on short-acting opioids (e.g., heroin, hydromorphone, fentanyl), as evidenced by either urine sample positive for recent opioid use during each visit or if opioid negative, displaying frank withdrawal during screening
- History of intravenous opioid use
- Baseline O2 saturation of 95% or greater
- Between the ages of 18-50 years
- Female subjects must be using an effective form of birth control (e.g., birth control pills, surgical sterilization, IUD, cervical cap with a spermicide, or abstinence). Urine pregnancy tests will be conducted prior to sessions to ensure that female subjects do not participate if pregnant
- Able to speak and read English
- Otherwise healthy
Ki nem vehet részt
- Contraindications for MRI scanning (e.g., pacemaker, metal implants, claustrophobia, or any other implanted medical device)
- Regular use of other medications, with the exception of hormone-based contraceptives for female subjects, daily multivitamins or short-term antibiotic prescriptions
- Seeking treatment for SUD or currently taking buprenorphine or methadone as the primary opioid of use
- History of, or current, clinically significant physical disease (e.g., respiratory disease [asthma, COPD, sleep apnea], impaired cardiovascular functioning, seizure disorder or CNS tumors) or current or past history of psychiatric disorder that would limit compliance in the studies, other than substance use disorder
- Meet diagnostic criteria for psychoactive substance use disorder for substances other than opioids (OUD subjects only) or nicotine/caffeine that would require detoxification (i.e., alcohol, benzodiazepines or barbiturates). Negative urine/breath samples for these substances, and the absence of withdrawal, will be required during screening
- Vision or hearing problems that would preclude completion of experimental tasks
- Poor venous access
- At risk for respiratory complications and have predictors of difficult bag mask ventilation (e.g., dentures, very full beard), in case emergency respiratory intervention is needed
Helyszínek itt: Egyesült Államok
- University of KentuckyLexington, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The objective of this protocol is to use probabilistic choice tasks to determine the impact of withdrawal and drug cues on decision-making in individuals with opioid use disorder and physical opioid dependence.
A vizsgálat csoportja
- Probabilistic Choice TaskA vizsgált kezelés
Subjects with opioid use disorder complete a probabilistic concurrent choice task under opioid maintained and withdrawn conditions. Three sessions include a money-vs-money task and three sessions include a drug-vs-money task. Monetary reward value is $0.25 or $4.00. Task option visual cues for the money-vs-money versions are colored envelopes or opioid-associated and matched neutral cues. Drug is an active dose of remifentanil.
Kezelés: Drug Cue, Money, Withdrawal és Remifentanil
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice
- A regiszteradat frissítve
- 2026. március 30.